Trial Profile

Efficacy and Safety Assessment of ZOlpidem (Stilnox CR) Administered on as Needed Basis in Patients With Chronic insomNIA.

Status: Completed

Phase of Trial: Phase IV

Latest Information Update: 12 Oct 2010

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Zolpidem (Primary)
Indications Insomnia
Focus Therapeutic Use
Sponsors Sanofi

Most Recent Events

04 Oct 2010 Actual end date (Jul 2010) added as reported by ClinicalTrials.gov.
04 Oct 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
14 Jun 2010 Planned end date changed from 1 Jun 2010 to 1 Aug 2010 as reported by ClinicalTrials.gov.

You need to be a logged in or subscribed to view this content Request demo (opens in a new window)

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com